A genomic approach to human autoimmune diseases

Virginia Pascual, Damien J. Chaussabel, Jacques Banchereau

Research output: Contribution to journalReview article

106 Citations (Scopus)

Abstract

The past decade has seen an explosion in the use of DNA-based microarrays. These techniques permit assessment of RNA abundance on a genome-wide scale. Medical applications emerged in the field of cancer, with studies of both solid tumors and hematological malignancies leading to the development of tests that are now used to personalize therapeutic options. Microarrays have also been used to analyze the blood transcriptome in a wide range of diseases. In human autoimmune diseases, these studies are showing potential for identifying therapeutic targets as well as biomarkers for diagnosis, assessment of disease activity, and response to treatment. More quantitative and sensitive high-throughput RNA profiling methods are starting to be available and will be necessary for transcriptome analyses to become routine tests in the clinical setting. We expect this to crystallize within the coming decade, as these methods become part of the personalized medicine armamentarium.

Original languageEnglish
Pages (from-to)535-571
Number of pages37
JournalAnnual Review of Immunology
Volume28
DOIs
Publication statusPublished - 23 Apr 2010
Externally publishedYes

Fingerprint

Autoimmune Diseases
Gene Expression Profiling
RNA
Precision Medicine
Explosions
Hematologic Neoplasms
Oligonucleotide Array Sequence Analysis
Neoplasms
Therapeutics
Biomarkers
Genome

Keywords

  • Biomarkers
  • Blood
  • Juvenile arthritis
  • Lupus
  • Microarray

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

A genomic approach to human autoimmune diseases. / Pascual, Virginia; Chaussabel, Damien J.; Banchereau, Jacques.

In: Annual Review of Immunology, Vol. 28, 23.04.2010, p. 535-571.

Research output: Contribution to journalReview article

Pascual, Virginia ; Chaussabel, Damien J. ; Banchereau, Jacques. / A genomic approach to human autoimmune diseases. In: Annual Review of Immunology. 2010 ; Vol. 28. pp. 535-571.
@article{34bd07c90c484260b7e2c00d9803e9b5,
title = "A genomic approach to human autoimmune diseases",
abstract = "The past decade has seen an explosion in the use of DNA-based microarrays. These techniques permit assessment of RNA abundance on a genome-wide scale. Medical applications emerged in the field of cancer, with studies of both solid tumors and hematological malignancies leading to the development of tests that are now used to personalize therapeutic options. Microarrays have also been used to analyze the blood transcriptome in a wide range of diseases. In human autoimmune diseases, these studies are showing potential for identifying therapeutic targets as well as biomarkers for diagnosis, assessment of disease activity, and response to treatment. More quantitative and sensitive high-throughput RNA profiling methods are starting to be available and will be necessary for transcriptome analyses to become routine tests in the clinical setting. We expect this to crystallize within the coming decade, as these methods become part of the personalized medicine armamentarium.",
keywords = "Biomarkers, Blood, Juvenile arthritis, Lupus, Microarray",
author = "Virginia Pascual and Chaussabel, {Damien J.} and Jacques Banchereau",
year = "2010",
month = "4",
day = "23",
doi = "10.1146/annurev-immunol-030409-101221",
language = "English",
volume = "28",
pages = "535--571",
journal = "Annual Review of Immunology",
issn = "0732-0582",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - A genomic approach to human autoimmune diseases

AU - Pascual, Virginia

AU - Chaussabel, Damien J.

AU - Banchereau, Jacques

PY - 2010/4/23

Y1 - 2010/4/23

N2 - The past decade has seen an explosion in the use of DNA-based microarrays. These techniques permit assessment of RNA abundance on a genome-wide scale. Medical applications emerged in the field of cancer, with studies of both solid tumors and hematological malignancies leading to the development of tests that are now used to personalize therapeutic options. Microarrays have also been used to analyze the blood transcriptome in a wide range of diseases. In human autoimmune diseases, these studies are showing potential for identifying therapeutic targets as well as biomarkers for diagnosis, assessment of disease activity, and response to treatment. More quantitative and sensitive high-throughput RNA profiling methods are starting to be available and will be necessary for transcriptome analyses to become routine tests in the clinical setting. We expect this to crystallize within the coming decade, as these methods become part of the personalized medicine armamentarium.

AB - The past decade has seen an explosion in the use of DNA-based microarrays. These techniques permit assessment of RNA abundance on a genome-wide scale. Medical applications emerged in the field of cancer, with studies of both solid tumors and hematological malignancies leading to the development of tests that are now used to personalize therapeutic options. Microarrays have also been used to analyze the blood transcriptome in a wide range of diseases. In human autoimmune diseases, these studies are showing potential for identifying therapeutic targets as well as biomarkers for diagnosis, assessment of disease activity, and response to treatment. More quantitative and sensitive high-throughput RNA profiling methods are starting to be available and will be necessary for transcriptome analyses to become routine tests in the clinical setting. We expect this to crystallize within the coming decade, as these methods become part of the personalized medicine armamentarium.

KW - Biomarkers

KW - Blood

KW - Juvenile arthritis

KW - Lupus

KW - Microarray

UR - http://www.scopus.com/inward/record.url?scp=77952318708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952318708&partnerID=8YFLogxK

U2 - 10.1146/annurev-immunol-030409-101221

DO - 10.1146/annurev-immunol-030409-101221

M3 - Review article

VL - 28

SP - 535

EP - 571

JO - Annual Review of Immunology

JF - Annual Review of Immunology

SN - 0732-0582

ER -